Costs of type 2 diabetes mellitus from payers’ perspective: a study from real-world evidence of district hospital in Vietnam


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. Estimate yearly treatment cost of type 2 diabetes mellitus (T2DM) from payers' perspective and its influencing factors. Method. A cross-sectional descriptive study has been conducted based on real-world evidence from Thu Duc district hospital from January 2017 to April 2018. Cost of T2DM was estimated based on payers' perspective and included direct medical, direct non-medical and indirect costs. Result: Analyzing the sample of 206 patients with men: women rate of 1: 2.81 and mean age of 61.76±9.74, it has been shown that the average costs of T2DM per patient was accounted for US 1,038.3(95 1,677.2 (95% CI 1,541.3-1,813.1), which is higher than those without complications (US 306.3(95 1,038.3; in which average cost for patients with complication was 5 times higher than those without complication. HbA1c level, comorbidities and complication were the first 3 factors influencing average cost of T2DM.

全文:

受限制的访问

作者简介

Thi Nguyen

Pharmacist, Department of Pharmacy

Email: nguyenthuthuy@ump.edu.vn
Pharmacist, Department of Pharmacy - Hospital of District Ho Chi Minh City, Viet Nam

Tran Nguyen

University of Medicine and Pharmacy

Email: nguyentrantrung0404@gmail.com
Pharmacist, Department of Pharmacy - Hospital of District Ho Chi Minh City, Viet Nam

Thi Pham

Thu Duc district hospital

Email: linhds2000@gmail.com
Pharmacist, Department of Pharmacy Ho Chi Minh City, Viet Nam

Quan Le

University of Medicine and Pharmacy

Email: lequannghiem55@gmail.com
Lecturer, Pharmacy faculty Ho Chi Minh City, Viet Nam

Minh Nguyen

Thu Duc district hospital

Email: quan_minhnguyen@yahoo.com
Director Ho Chi Minh City, Viet Nam

参考

  1. Association American Diabetes (2013), «Economic costs of diabetes in the US in 2012», Diabetes care. 36 (4): 1033-46.
  2. Association American Diabetes (2013), «Economic costs of diabetes in the US in 2012. Diabetes Care. 2013; 36: 103346», Diabetes care. 36 (6): 1797.
  3. Association American Diabetes (2016), «Standards of medical care in diabetes-2016 abridged for primary care providers», Clinical diabetes: a publication of the American Diabetes Association. 2016; 34 (1): 3.
  4. Bahia Luciana R. et al., «The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system», Value in Health. 2011; 14 (5): 137-40.
  5. Bloomberg, «https://www.bloomberg.com/quote/ USDVND:CUR». Accessed: June 17, 2018.
  6. Bloomberg, «www.bloomberg.com/quote/ USDVND:CUR». Acessess: June 9, 2018.
  7. Cao Ping et al., «Factors influencing the hospitalization costs of patients with type 2 diabetes», Asia Pacific Journal of Public Health. 2015; 27 (2_suppl): 55-60.
  8. Chatterjee Susmita et al., «Cost of diabetes and its complications in Thailand: a complete picture of economic burden», Health & social care in the community. 2011; 19 (3): 289-98.
  9. Esteghamati A. et al. «The economic costs of diabetes: a population-based study in Tehran, Iran», Diabetologia. 2009; 52 (8): 1520-7.
  10. Gardner David G. et al. Greenspan's basic & clinical endocrinology, McGraw-Hill Medical. 2007.
  11. Internasional Diabetes Federation. «IDF diabetes atlas», Brussels: International Diabetes Federation. 2013.
  12. Köster Ingrid et al. «Direct costs of diabetes mellitus in Germany-CoDiM 2000-2007», Experimental and Clinical Endocrinology & Diabetes. 2011; 119 (06): 377-85.
  13. Le Nguyen Tu Dang et al. «Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study», Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2017; 10: 363.
  14. Lee Crystal Man Ying et al. «The cost of diabetes in adults in Australia», Diabetes Research and Clinical Practice. 2013; 99 (3): 385-90.
  15. Ng Charmaine Shuyu et al. «Direct medical cost of type 2 diabetes in Singapore», PloS one. 2015; 10 (3): e0122795.
  16. Nguyen Chung T. et al. «Prevalence of and risk factors for type 2 diabetes mellitus in Vietnam: a systematic review», Asia Pacific Journal of Public Health. 2015; 27 (6): 588-600.
  17. Organization World Health, Global report on diabetes, World Health Organization. 2016.
  18. Shi Yuankai et al. «The global implications of diabetes and cancer», The Lancet. 2014; 383 (9933): 1947-8.
  19. Shourov D.M. A Survey on Prescription Pattern of Diabetes Mellitus, East West University. 2017.
  20. Solli Oddvar et al. «Diabetes: cost of illness in Norway», BMC endocrine disorders. 2010; 10 (1): 15.
  21. Tao Ziqi et al. «Epidemiological perspectives of diabetes», Cell biochemistry and biophysics. 2015; 73 (1): 181-5.
  22. Tharkar Shabana et al. «The socioeconomics of diabetes from a developing country: a population based cost of illness study», Diabetes Research and Clinical Practice. 2010; 89 (3): 334-40.
  23. The World Heaith Organization Representative Office in Viet Nam (2016), «The growing burden of diabetes in Viet Nam», WPRO, <http://www.wpro.who.int/vietnam/mediacentre/features /feature_world_health_day_2016_vietnam/en/>. Accessed: March 27, 2018.
  24. Wang Weibing et al. «Type 2 diabetes mellitus in China: a preventable economic burden», The American journal of managed care. 2009; 15 (9): 593-601.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2020